Skip to main content
. 2022 Dec 29;14:146. doi: 10.1186/s13073-022-01151-6

Fig. 3.

Fig. 3

Sensitivity of Omicron subvariants to therapeutic bebtelovimab. a Neutralization curves against D614G, Delta, and Omicron subvariants are shown for bebtelovimab. Data are the mean ± s.d. of 2 independent experiments, each with an intra-assay duplicate. b Fifty percent and 90% inhibition concentration (IC50 and IC90) values against D614G, Delta, and Omicron subvariants are shown for bebtelovimab. IC50 and IC90 values were calculated from two independent experiments. c Fold change of IC50 and IC90 of the antibody against Delta and each Omicron subvariant compared to D614G. The horizontal dotted lines represent IC50 and IC90